αV integrin antagonists for the treatment of idiopathic pulmonary fibrosis

The design and synthesis of targeted BET inhibitors

Novel C-C bond formation strategies for access to secondary and tertiary amides enabled by new synthetic technologies

Design and synthesis of dimethylisoxazole quinolines as BET inhibitors

Targeted protein degradation as a new approach to drug discovery

Use of fragment-based drug discovery to identify novel drug molecules for challenging biological targets, including protein-protein interactions

The application of flow chemistry to the synthesis of pharmaceutically privileged heterocycles